Raf inhibitor compounds

US8741911B2 · kind B2 · utility

Assignees

• ELI LILLY AND COMPANY · US
• Deciphera Pharmaceuticals, LLC · US

Inventors

• Matthew Carl Allgeier · Fishers, US
• Daniel L. Flynn · Lawrence, US
• Michael D. Kaufman · Waltham, US
• Phenil Jayantilal Patel · Carmel, US
• Craig Daniel Wolfangel · Carmel, US

Key dates

• Filing date: Mar 5, 2013
• Grant date: Jun 3, 2014
• Expiry date: Mar 5, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides a pyrido[2,3-d]pyrimidine compound, or a pharmaceutically acceptable salt thereof, that inhibits Raf and, therefore, may be useful in treating cancer.